A novel therapeutic anti-ErbB3, ISU104 exhibits potent antitumorigenic activity by inhibiting ligand binding and ErbB3 heterodimerization M Hong, Y Yoo, M Kim, JY Kim, JS Cha, MK Choi, U Kim, K Kim, Y Sohn, ... Molecular Cancer Therapeutics 20 (6), 1142-1152, 2021 | 7 | 2021 |